The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Linn Reinholdt (Creator)
Maria Bach Laursen (Creator)
Alexander Schmitz (Creator)
Julie Støve Bødker (Aalborg University) (Creator)
Lasse Hjort Kyneb Jakobsen (Creator)
Martin Bøgsted (Creator)
Hans Erik Johnsen (Aalborg University) (Creator)
Karen Dybkær (Contributor)

Dataset

1 Journal article

1 results

2016
The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Reinholdt, L., Laursen, M. B., Schmitz, A., Bødker, J. S., Jakobsen, L. H., Bøgsted, M., Johnsen, H. E. & Dybkær, K., 2016, In: Biomarker Research. 4, 12 p., 12.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
30 Citations (Scopus)